Clinical Trials Browser

Phase 2 × INDUSTRY × Breakthrough Cancer Pain × Clear all

NCT05531422 2024-06-12

Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With BTcP

Phase 2 Completed

Breakthrough Cancer Pain